New 40-Minute Diagnostic Test Speeds Up Rocky Mountain Spotted Fever Detection

Researchers at the University of Missouri have developed a new 40-minute diagnostic test for Rocky Mountain spotted fever, potentially replacing slower, costlier methods. Published in Frontiers in Microbiology, the study, “A rapid isothermal RPA–CRISPR/Cas12a assay for detection of Rickettsia rickettsii,” outlines an assay that uses RPA–CRISPR/Cas12a technology to detect the bacteria at room temperature, offering a vital tool for rural and under-resourced clinical settings.

A Faster Detection Method for Rickettsia rickettsii

Currently, patients suffering from Rocky Mountain spotted fever—a disease that can progress from a tick bite to severe fever, headache, and rash within days—often face diagnostic delays that impact treatment outcomes. Existing diagnostic tools can be expensive, hard to access, or unable to detect small amounts of the bacteria in a blood sample.

According to research from the University of Missouri, the test requires only two 20-minute steps to process a blood sample. By mixing DNA from a sample with specialized reagents at room temperature, clinicians can obtain results in 40 minutes, marked by a visible change in liquid color that indicates a positive detection of the bacteria. This eliminates the requirement for complex and costly laboratory equipment, which often serves as a barrier to timely testing in remote or rural areas. The test specifically targets the R. rickettsii vut gene.

Unfortunately, this disease can be particularly deadly in children if diagnosis is delayed, and often patients may not realize they have been bitten by a tick until they feel extremely ill, said Roman Ganta. Quicker diagnosis leads to quicker treatment with doxycycline, so we are hopeful our research can improve outcomes for those impacted.

Clinical Application and Future Deployment

While the test offers a significant technical leap, its path to widespread clinical use is still in the planning stages. Roman Ganta has initiated discussions with the Veterinary Medical Diagnostic Laboratory at the University of Missouri to evaluate how the assay might be integrated into real-world clinical applications. The ultimate goal is to provide a portable, accessible solution for under-resourced healthcare providers globally.

Currently, the antibiotic doxycycline is used to treat the disease, and clinicians often prescribe it while waiting for confirmatory results from traditional, slower diagnostic methods. This new assay aims to reduce that period of uncertainty. As Ganta noted, By making this test more accessible, more patients can benefit from our work one day.

The Shifting Landscape of Vector-Borne Illness

The innovation at the University of Missouri arrives amid a broader, concerning trend in the United States: the expansion of tick-borne and vector-borne diseases into new geographic regions. Experts warn that climate change, shifting tick habitats, and increased global travel are contributing to the rise of both known and emerging pathogens.

According to reporting by Newsweek, physicians are seeing an increase in infections like anaplasmosis, which is transmitted by the blacklegged deer tick. Anaplasmosis causes fever, headache, chills, and muscle aches, but unlike Lyme disease, it produces no bull’s-eye rash, making it easy for patients and doctors to miss without a blood test. Dr. Natasha Wyndham Hanners, an infectious disease specialist at Children’s Health and Assistant Professor at UT Southwestern Medical Center, noted that it is true that both mosquito and tick-borne illness reports, more inclusively called 'vector-borne' illnesses, are increasing, in part possibly due to regional climate changes and expanding insect and tick habitats. She added, It is also true that ease of worldwide travel along with more advanced diagnostic techniques are revealing emergence of previously unknown organisms or organisms new to an area.

Parallel to these concerns, researchers are investigating how various tick-borne viruses, such as those in the nairovirus family, have developed mechanisms to evade the human immune system. A study from the University of California, Riverside, highlighted in the same reporting, shows how a family of viruses called orthonairoviruses can suppress the body’s ability to detect infection by stripping away the immune system’s warning signals. While these findings focus on different pathogens than Rocky Mountain spotted fever, they underscore a growing public health priority: the need for more sophisticated, rapid, and accessible diagnostic tools to keep pace with an evolving threat environment.

Worth a look


Discover more from Archyworldys

Subscribe to get the latest posts sent to your email.